Allworth Financial’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,783
Closed -$961K 5237
2026
Q1
$961K Buy
+4,783
New +$989K ﹤0.01% 724
2025
Q4
Sell
-5,993
Closed -$1.07M 5096
2025
Q3
$1.07M Hold
5,993
﹤0.01% 646
2025
Q2
$967K Buy
5,993
+978
+20% +$156K ﹤0.01% 653
2025
Q1
$805K Sell
5,015
-558
-10% -$96.9K ﹤0.01% 575
2024
Q4
$989K Buy
5,573
+5,432
+3,852% +$928K 0.01% 543
2024
Q3
$24.3K Hold
141
﹤0.01% 1790
2024
Q2
$22.6K Buy
141
+77
+120% +$11.6K ﹤0.01% 1801
2024
Q1
$9.84K Hold
64
﹤0.01% 2123
2023
Q4
$10.1K Hold
64
﹤0.01% 1976
2023
Q3
$9.37K Hold
64
﹤0.01% 1865
2023
Q2
$9.8K Hold
64
﹤0.01% 1867
2023
Q1
$9.92K Hold
64
﹤0.01% 1794
2022
Q4
$9.86K Hold
64
﹤0.01% 1691
2022
Q3
$8K Hold
64
﹤0.01% 1739
2022
Q2
$9K Hold
64
﹤0.01% 1599
2022
Q1
$10K Sell
64
-59
-48% -$8.73K ﹤0.01% 1481
2021
Q4
$20K Buy
+123
New +$19.9K ﹤0.01% 1119
2019
Q2
Sell
-38
Closed -$6K 969
2019
Q1
$6K Buy
+38
New +$5.47K ﹤0.01% 645

Other funds holding FBT

Allworth Financial's FBT Position: Q2 2026 in Review

Allworth Financial sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2026, closing a stake of 4,783 shares — an estimated $961K sold.

Allworth Financial first reported a position in FBT in Q1 2019 and held it in 18 quarters. The position peaked at $1.07M in Q3 2025. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Allworth Financial reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2026 after selling out during the quarter.
  • Allworth Financial sold 4,783 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $961K.
  • Allworth Financial first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2019 and held it in 18 quarters.
  • Allworth Financial's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.07M in Q3 2025.
  • 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.